Pakistan faces a critical shortage of over 100 essential medicines, including life-saving drugs. Delayed price revisions by the Drug Regulatory Authority of Pakistan are disrupting production. Rising costs of raw materials and currency depreciation have impacted manufacturing expenses significantly. This situation is creating space for counterfeit and substandard products in the market. Industry representatives urge the government to approve pending hardship pricing cases immediately.
Related Posts
‘Removed in error’: Meta responds after PM Modi’s video was blocked on Facebook
Meta admitted to mistakenly deleting Prime Minister Narendra Modi’s video. The content was removed in error and has since been…
Why Nvidia CEO Jensen Huang is funding an art college in San Francisco
Nvidia CEO Jensen Huang and wife Lori have pledged $75 million to Vanderbilt University’s San Francisco campus, creating the Jen-Hsun…
101 murder accused among 989 with criminal records in Parliament march violence: Delhi Police
Delhi Police investigation identified criminals involved in the July 20 Parliament march violence. Many individuals with murder and dacoity charges…